Literature DB >> 8701976

Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice.

X Zhou1, S Stemme, G K Hansson.   

Abstract

It has been suggested that immune responses are involved in the development of atherosclerosis. We have evaluated this possibility by analyzing immunocompetent cells in a murine model of the disease. Apolipoprotein E knockout (apoE -/-) mice are genetically hypercholesterolemic due to targeted disruption of the apolipoprotein E gene and develop severe atherosclerosis. Such mice were fed either standard pellets or a diet containing 1.25% cholesterol. Lesions were analyzed from mice at 9 and 16 weeks of age. Immunohistochemical staining of fatty streaks showed that CD4+ T cells were frequent, both in clusters and as single cells. In advanced atherosclerotic plaques, CD4+ T cells were prominent in the fibrous cap and subendotbelially, whereas CD8+ T cells were sparse. The CD25 subunit of the interleukin-2 receptor, which is a marker for activated T cells, was expressed in CD4-rich areas and the major histocompatibility complex class II antigen, I-A(b), which is induced by cytokines released from activated T cells, was also found in the lesions. These data indicate that CD4+ T cells participate in the formation of atherosclerotic lesions in genetically hypercholesterolemic apoE -/- mice. They suggest that immune activation is part of the disease process, and we speculate that a direct link may exist between cholesterol accumulation and T cell activation, possibly by autoimmune responses to modified lipoproteins.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8701976      PMCID: PMC1865326     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  37 in total

Review 1.  Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions.

Authors:  P Libby; G K Hansson
Journal:  Lab Invest       Date:  1991-01       Impact factor: 5.662

2.  Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response.

Authors:  A C van der Wal; P K Das; D Bentz van de Berg; C M van der Loos; A E Becker
Journal:  Lab Invest       Date:  1989-08       Impact factor: 5.662

Review 3.  Immune mechanisms in atherosclerosis.

Authors:  G K Hansson; L Jonasson; P S Seifert; S Stemme
Journal:  Arteriosclerosis       Date:  1989 Sep-Oct

4.  Gene expression in macrophage-rich human atherosclerotic lesions. 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts.

Authors:  S Ylä-Herttuala; M E Rosenfeld; S Parthasarathy; E Sigal; T Särkioja; J L Witztum; D Steinberg
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

5.  Synthesis of IL-1 alpha and IL-1 beta by arterial cells in atherosclerosis.

Authors:  C F Moyer; D Sajuthi; H Tulli; J K Williams
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

6.  Detection of activated T lymphocytes in the human atherosclerotic plaque.

Authors:  G K Hansson; J Holm; L Jonasson
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

7.  Tumor necrosis factor gene expression in human vascular intimal smooth muscle cells detected by in situ hybridization.

Authors:  P Barath; M C Fishbein; J Cao; J Berenson; R H Helfant; J S Forrester
Journal:  Am J Pathol       Date:  1990-09       Impact factor: 4.307

Review 8.  The molecular cell biology of interferon-gamma and its receptor.

Authors:  M A Farrar; R D Schreiber
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

9.  T lymphocytes in aortic and coronary intimas. Their potential role in atherogenesis.

Authors:  E E Emeson; A L Robertson
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

10.  Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells.

Authors:  G K Hansson; M Hellstrand; L Rymo; L Rubbia; G Gabbiani
Journal:  J Exp Med       Date:  1989-11-01       Impact factor: 14.307

View more
  63 in total

1.  Quantification of Various Inflammatory Cells in Advanced Atherosclerotic Plaques.

Authors:  Veronica Soundra Veena Paul; Christina Mary Priya Paul; Sarah Kuruvilla
Journal:  J Clin Diagn Res       Date:  2016-05-01

Review 2.  Helper T cells and atherosclerosis: the cytokine web.

Authors:  S G Baidya; Q-T Zeng
Journal:  Postgrad Med J       Date:  2005-12       Impact factor: 2.401

Review 3.  Immunology of atherosclerosis: the promise of mouse models.

Authors:  A H Lichtman; M Cybulsky; F W Luscinskas
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

4.  Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice.

Authors:  Giuseppina Caligiuri; Antonino Nicoletti; Bruno Poirier; Göran K Hansson
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

5.  Statins reduce endothelial cell apoptosis via inhibition of TRAIL expression on activated CD4 T cells in acute coronary syndrome.

Authors:  Kayoko Sato; Toshiyuki Nuki; Keiko Gomita; Cornelia M Weyand; Nobuhisa Hagiwara
Journal:  Atherosclerosis       Date:  2010-04-04       Impact factor: 5.162

6.  Deleting TCR alpha beta+ or CD4+ T lymphocytes leads to opposite effects on site-specific atherosclerosis in female apolipoprotein E-deficient mice.

Authors:  Rima Elhage; Pierre Gourdy; Laurent Brouchet; Jacek Jawien; Marie-José Fouque; Catherine Fiévet; Xavier Huc; Yara Barreira; Jean Claude Couloumiers; Jean-François Arnal; Francis Bayard
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

7.  Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice.

Authors:  A Nicoletti; S Kaveri; G Caligiuri; J Bariéty; G K Hansson
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

8.  Lymphocyte subset characterization in patients with early clinical presentation of coronary heart disease.

Authors:  Natale Daniele Brunetti; Carmine D'Antuono; Michele Rana; Girolamo D'Arienzo; Luisa De Gennaro; Matteo Di Biase
Journal:  J Thromb Thrombolysis       Date:  2012-11       Impact factor: 2.300

Review 9.  Adaptive immunity and atherosclerosis: mouse tales in the AJP.

Authors:  Andrew H Lichtman
Journal:  Am J Pathol       Date:  2012-11-16       Impact factor: 4.307

10.  Mildly oxidized low-density lipoproteins decrease early production of interleukin 2 and nuclear factor kappaB binding to DNA in activated T-lymphocytes.

Authors:  S Caspar-Bauguil; J Tkaczuk; M J Haure; M Durand; J Alcouffe; M Thomsen; R Salvayre; H Benoist
Journal:  Biochem J       Date:  1999-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.